Sponsor-Investigators

Veronika Bachanova

BTCRC-HEM15-027

Phase I/II Study of Nivolumab in Combination with Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma: BTCRC-HEM15-027

Status

Cancer Types

Lymphoma

Locations

Masonic Cancer Center, University of Minnesota, University of Iowa Holden Comprehensive Cancer Center, University of Wisconsin Carbone Cancer Center